BDP FL DBCO is a PEG analogue containing a reactive DBCO group. DBCO will react with azide-bearing compounds or biomolecules to form a stable triazole linkage without copper catalyst. References: Wang H, Tang L, Liu Y, Dobrucka IT, Dobrucki LW, Yin L, Cheng J. In Vivo Targeting of Metabolically Labeled Cancers with Ultra-Small Silica Nanoconjugates. Theranostics. 2016 Jun 16;6(9):1467-76. doi: 10.7150/thno.16003. eCollection 2016. PubMed PMID: 27375793; PubMed Central PMCID: PMC4924513.

纯度：≥98%

CAS：2093197-94-3